RVMD
Revolution Medicines, Inc.Company with tickers: RVMD, RVMDW
CIK
1628171
CUSIP
76155X100
Shares Outstanding
212,596,462
Website
https://www.revmed.com
13F Activity (30d)
6 filings
4 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $445,222,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Research & Development | $343,970,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $-445,222,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $-453,816,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $-2.29 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $-2.29 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Product & Service (USD)
| Component | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Collaboration Revenue | $50,041,000 | $42,983,000 | $29,390,000 | $35,380,000 |